Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes monitoring for recurrence more important during titration.
20 likes 23mo
Topic summary
[2026 update] People with a low starting BMI: where the evidence stops
This is a generated summary. It shows the 5 most-liked posts from a topic of 24, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
v.bhattacharya, post #1: People with a low starting BMI: where the evidence stops Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The published trials in this class mostly enrolled a fairly specific group, and the questions here frequently come from people well outside it.… Go to post
Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1 agonist requires insulin dose reduction and close monitoring for hypoglycemia. This is manageable with attention.
methods_margin, post #6: For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use. Go to post
post #18 answers the question as asked. The question underneath it is different.
Pregnancy and planning: these compounds are not approved for use in pregnancy. Planning windows (how long to wait before attempting pregnancy) are not formally established. Conservative approaches wait several months to allow clearance.
Disordered eating history: a history of anorexia nervosa, bulimia, or other eating disorders changes the risk-benefit calculation because appetite suppression might trigger relapse. This population requires specialist input.
24 likes 23mo
Read the full topic (24 posts)
This topic was referenced in
- Athletes in weight-category sports: a different risk calculus — a second datasetClinical › Special populations · 41 replies
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Athletes in weight-category sports: a different risk calculus — a second dataset
On the subject in the title: Athletes in weight-category sports: a different risk calculus — a second dataset Working notes rather than a conclusion. General question, not a request for advice about my own…
|
+37 | 41 | 16k | 20mo |
|
Pregnancy and pregnancy planning: contraindication and washout
Posting this under the heading it deserves: Pregnancy and pregnancy planning: contraindication and washout Everything below is what sits behind that. General question, not a request for advice about my own…
|
+111 | 122 | 2.4k | 3mo |
|
Coming back to: Bariatric surgery history: altered anatomy, altered expectations
Bariatric surgery history: altered anatomy, altered expectations Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The…
|
2 | 38k | 15mo | |
|
People with a low starting BMI: where the evidence stops
Posting this under the heading it deserves: People with a low starting BMI: where the evidence stops Everything below is what sits behind that. Asking about a population rather than about a person. The…
|
+23 | 27 | 5.8k | 19mo |
|
Type 1 diabetes: off-label use and the evidence gap — what changed since
Type 1 diabetes: off-label use and the evidence gap — what changed since — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The…
|
+68 | 77 | 31k | 20mo |
Related topics — sharing the tags chronic kidney disease, adolescents, pregnancy & planning
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Hypertension improvement and when medication needs revisiting
Hypertension improvement and when medication needs revisiting Writing it up because I had to work it out twice and would rather nobody else did. Asking about a population rather than about a person. The…
|
+74 | 79 | 1.1k | 10mo |
|
Revisiting: Heart failure with preserved ejection fraction: symptom endpoints
On the subject in the title: Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Working notes rather than a conclusion. General question, not a request for advice about my own care…
|
+4 | 8 | 43k | 17mo |
|
Pregnancy as an absolute contraindication
Pregnancy as an absolute contraindication — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published trials in this class mostly…
|
+102 | 106 | 21k | 14mo |
|
Type 2 diabetes and the largest part of the evidence base — does this still hold?
Type 2 diabetes and the largest part of the evidence base — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Asking about a population rather…
|
+18 | 25 | 1.7k | 22mo |
|
Coming back to: Renal impairment: what the labelling says about dose
Renal impairment: what the labelling says about dose — setting out what I have, and where I think it stops being reliable. Asking about a population rather than about a person. The published trials in this…
|
+30 | 34 | 48k | 18mo |